Skiteam #CIP2A demonstrated admirable attitude and performance on yesterday´s training session. Some of the bravest with training background from the past years already approached the 3 km track with up and downhills. #lifeinfinland @westermarcklab.bsky.social #lifeoutsidethelab

Registration is now OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org

Santa Claus paid a surprise visit to our last lab development meeting and brought nice @westermarcklab.bsky.social mugs as a gift to everyone, also to the naughty boy. With these images we wish everyone happy holidays and merry Christmas.

We have a group leader position open surrounded by fantastic core facilities and great science @turkubioscience.bsky.social.

Farewell to @muksha.bsky.social. a proud recipient of the first @westermarcklab mug. Huge thanks for all your contributions and best of luck on your new adventures @mdanderson.bsky.social

Great fun yesterday celebrating the recent Tillandz prize with the lab and collaborators. Also remotely joining the man of the hour, Majid Momeny aka the first author of the paper.

@srikarnagelli.bsky.social back on the crime scene. Always good to have alumni visiting the lab and sharing their new knowledge

Congrats @shrutibhardiya.bsky.social @westermarcklab.bsky.social for winning the best poster prize at 7th @fibtra.bsky.social annual Brain Tumor meeting. Excellent meeting, thanks to all organisers 💪

Very exciting talk by Alberto Ballestin on acute impact of surgery on glioblastoma tissue @fibtra.bsky.social annual symposium in Turku.

#CIP2A has a druggable pocket. I am thrilled to announce that the last of my #CIP2A bucket list items, established 2007 has finally been accomplished. The work now out in BioRxiv reports a small molecule druggable pocket on CIP2A 1/2 www.biorxiv.org/content/10.1...

Have you heard of #CIP2A, a hot new kid on the block of genome integrity and DNA repair? Funny enough, most of these papers hardly mention CIP2A as PP2A inhibitor covered by about 400 papers. This is really exciting developments for sure, an eventually these oncogenic arms of CIP2A will merge.

#careergoals after all these years I was finally rewarded by a whiteboard in my office.😁 Had to start using it immediately.

Elias Tillandz Prize awarded at the BioCity Symposium to scientific publications on breast cancer recurrence and cancer gene overactivation www.utu.fi/en/news/pres...

August issue now online! ➡️ www.embopress.org/toc/17574684... The cover highlights the study by X Qiao, J Routila, J Westermarck, S Ventelä & al @westermarcklab.bsky.social showing that LIMA1 detection can be used for #HNSCC patients stratification Scientific image by M. Peltola, Thestra Oy, Turku

We are on the cover! Or what is in the cover is way more important than we, it's evidence that simple IHC assay could be used for recognising #HNSCC patients based on their outcome after surgery-only therapy. The actual cover and the article can be found here: www.embopress.org/doi/full/10....

Particularly proud of this collaboration with Sami Ventela and all Finnish #HNSCC clinics revealing LIMA1-alpha as translatable biomarker for selection of HNSCC patients for surgery-only therapies. www.utu.fi/en/news/pres... www.embopress.org/doi/full/10....

Very nice bioinformatics analysis of the role of #CIP2A in ovarian cancer by @karteris.bsky.social rdcu.be/exid3

Lab cleaning day is one of the important @westermarcklab.bsky.social traditions. This year the after-cleaning pizzas were enjoyed in sunny Kupittaa park. Thanks Tiina for organization and everyone for your efforts

Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live? Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland: www.unil.ch/dof/en/home/... ⏰ Deadline 27 June

We’ve just marked a major milestone - our community of cancer researchers now numbers 14 000 members, working across 117 countries worldwide 🎉 Thank you to you, our members, for your ongoing support and commitment to advancing cancer research. Your passion and dedication inspire everything we do.

Fantastic EACR @helloeacr.bsky.social annual congress in Lisbon. Great talks Great atmosphere Great to meet all old and new friends

Lukijoilta | Tohtorintutkinto tulisi ottaa OKM:n ylimmän johdon pätevyysvaatimukseksi www.ts.fi/lukijoilta/6...

Absolutely catapulting quadrable WEKK (Westermarck, Elenius, Kurppa, Kauko) retreat @Villa Wolax. Fantastic science, discussions, sauna, food, wine, colleagues @turkubioscience.bsky.social @medicity.bsky.social

Want to relocate to Finland as a professor in the fields of basic, clinical, or translational medicine. An exciting funding opportunity. Please be on contact if I can be of any help. www.sigridjuselius.fi/en/apurahat/...

Early-stage, curiosity-driven cancer research is the cornerstone of future medical breakthroughs. Let's #KeepResearchCurious ✨

New preprint from us. The study led by Mukund Sharma demonstrates how #PP2A mediated dephosphorylation of serine 166 of LSD1 functions as a phosphorylation switch between gene repression and activation by LSD1 and how this shapes tumor microenvironment. www.biorxiv.org/content/10.1...

Very exciting program for the next year @helloeacr.bsky.social "Signaling Circuits in Cancer" virtual meeting just published. Scientific programme | Signalling Circuits in Cancer | The European Association for Cancer Research url:https://eacr.org/conference/signallingcircuits2026/sc

Very important milestone for Finnish academic drug development. The recently established Finnish Drug Development Center has started its first drug development project in collaboration with a start-up Kohde Pharma. ddcenter.fi/kohde-pharma...

Great news for European science

Always great to see @westermarcklab.bsky.social alumni. This time very heartwarming breakfast with Melissa Junttila at #AACR2025

A new model figure why #CIP2A is such a potent therapy target for #TNBC and other homologous recombination deficient cancers. Two punch effect by hitting one protein; both DNA repair and #PP2A regulated oncogenicity/proliferation inhibited by CIP2A inhibition.

Still possible to register and submit your abstract for the best cancer meeting for 2025!

Running a lab involves lots of maintenance and technical development. We started this year to have bi-weekly Laboratory development meetings for this purpose. Very useful experience so far, Thanks everyone for your efforts🙏

Oh boy, #PP2A again contaminating #phosphatase research. First it was physiological PP2A binding that explained the S/T PPase activity of Eye, now it is a real contamination of PHLPP1/2 protein preps. Important work that forces to entirely rethink the past literature on PHLPPs.

New #PP2A research tools in @addgene.bsky.social by us. PME-1 lentivirus overexpression vectors for wild type and methylesterase and PP2Ac binding mutants www.addgene.org/browse/artic... Please check also our entire collection including various CIP2A tools. Enjoy www.addgene.org/Jukka_Wester...

My US-based colleagues, FYI: Finnish Research Council is about to announce a special call to fund researchers abroad to relocate to Finland. By all means this is not intended to lure you into moving to Finland, it just happens to be planned right now by pure chance.

Come join us for the phosphatase meeting this summer! Deadline approaching for signing up for this great meeting. meetings.embo.org/event/25-pho...

Very exciting beginning of @helloeacr.bsky.social Persister Cells meeting in spring of Lyon

Always happy to follow the success of the @westermarcklab.bsky.social alumni. Warmest congratulations to Majid for his most recent achievement. med.uth.edu/blog/2025/01...

The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...

@westermarcklab.bsky.social proudly presents: The lab logo. Only took 23 years to have it done, but here it is. Big credits to Henok Karvonen at @turkubioscience.bsky.social for beautiful design. Embedded cancer cell #signaling by #phosphorylation and #dephosphorylation #phosphatase

Huge congrats Aman! We are very proud to follow your career success as the @westermarcklab.bsky.social @turkubioscience.bsky.social alumni, keep up the great work! www.linkedin.com/posts/amanpr...

@westermarcklab.bsky.social will surely be there, come along, promises to be a really exciting meeting.

What pays off if the goal is to secure a faculty position in academia. Emphasises big papers and post-doc career rather than PhD. Not surprising but unfortunately puts even more emphasis on hitting a breakthrough paper rather than building persistently certain research direction.

Hello, world! 🌟 We're thrilled to join the BlueSky community! Excited to connect with so many amazing people & organizations here. Let’s collaborate, share, and grow together. Can’t wait to hear from you all! 💬💙

If you’re thinking of what meeting to go to this year then check out the #phosphatase meeting in Würzburg. Lots of great speaking slots and events for junior researchers. It’s always a fun meeting meetings.embo.org/event/25-pho...

If you are looking for one cancer meeting to attend this year in Europe, here it is! Cool science, fantastic location, excellent organisation.

Looks like another fantastic proteomics data tool from the @kusterlab.bsky.social Thanks a lot, must read for sure.

Here we are, happy to join the community!